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Summary 
 
The outbreak of drug resistant pathogens, the high cost of health care, limited accessibility of the 
conventional drugs and their side effects are problems that make the treatment of infectious diseases 
difficult all over the world. These challenges have led to the search for novel drugs and drug leads that 
can surpass the quality of the currently available antimicrobial agents. Medicinal plants are considered 
to be the best candidates for the discovery of new drugs because of their long history of use in the 
treatment of various ailments in communities. The current study was aimed at investigating the 
antimicrobial activity, cytotoxic activity and phytochemical composition of the methanol extracts from 
Buxus macowanii, Polygala myrtifolia, Scilla sp. and Xanthocercis zambesiaca. 
 
Staphylococcus aureus, Clostridium perfringens, Pseudomonas aeruginosa, Enterococcus faecalis, 
Escherichia coli, Staphylococcus epidermidis, and the fungal species Candida albicans and Candida 
tropicalis were used to evaluate the antimicrobial activity of the selected plant extracts using the broth 
Microdilution method. All the plants extracts tested showed no activity against all the bacterial and 
fungal species except Buxus macowanii. Buxus macowanii inhibited the growth of Staphylococcus 
aureus, Clostridium perfringens, Pseudomonas aeruginosa, Staphylococcus epidermidis, Candida 
albicans and Candida tropicalis at the MIC of 2.5 mg/ml while Enterococcus faecalis and Escherichia 
coli were inhibited at 1.2 mg/ml.  
 
Buxus macowanii was selected for further studies because it presented the best antimicrobial 
properties. Antimicrobial compounds were located using TLC bioautography.  Four clear zones possibly 
flavonoids and alkaloids were detected on the TLC chromatogram. These findings suggest that the 
antimicrobial activity of Buxus macowanii was not attributed to a single compound but to a synergy of 
compounds. The effect of Buxus macowanii on the bacterial cell morphology was also evaluated. 
Morphological changes such as damage to the cell wall, loss of intracellular contents, incomplete cell 
© Central University of Technology, Free State
V 
 
division and shrinkage of the cells were observed using Scanning and Transmission Electron 
Microscopy. Bacterial cells were affected morphologically after treatment with the extracts of B. 
macowanii. 
 
In order to evaluate the safety of the extracts used in the study, the Sulforhodamine cytotoxicity assay 
was carried out using the WI-38 cell line (Normal human fetal lung fibroblast). P. myrtifolia was inactive 
against the WI-38 cell line whereas B. macowanii and X. zambesiaca were found to be moderately 
hazardous. Scilla extracts were found to be hazardous. These results indicate that caution should be 
exercised when employing plants like B. macowanii, X. zambesiaca and Scilla sp. for treatment of 
ailments.  
 
The phytochemical screening of B. macowanii, P. myrtifolia, Scilla and X. zambesiaca using standard 
methods, TLC and GCMS revealed compounds that have important health benefits. Bioactive 
compounds such as flavonoids, alkaloids, terpenes, cardiac glycosides, steroids, saponins and tannins 
were found in most of the extracts and their presence may explain the medicinal usage of the plants. 
GCMS also revealed compounds such as neophytadiene that was found in the extracts of Buxus 
macowanii, n-hexadecanoic was also found in the extracts of scilla sp and X. zambesiaca. 2-methoxy-
4-vinylphenol was found in the extracts of P. myrtifolia and X. zambesiaca. 
 
The results obtained in this study show that B. macowanii is a promising source of antimicrobial drugs. 
Further investigation into the isolation and identification of the bioactive compounds as well as in vivo 
screening is recommended.  
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CHAPTER 1 
1. INTRODUCTION 
 
1.1. The burden of infectious diseases 
Infectious diseases continue to kill millions of people every year. They are the second leading cause of 
death in the world and the leading cause of death in individuals under the age of 50 (Hamburg, 2008). 
The human immunodeficiency virus (HIV), tuberculosis (TB) and malaria are among the five major 
infectious diseases that contribute to the death rate of people world-wide (Feachem, 2004). Statistics 
released by the World Health Organisation (WHO) in 2014 indicated that approximately 36.9 million 
people live with HIV, while 2 million people were recorded as newly infected (WHO, 2014a). TB has a 
high rate of drug resistance. In 2013, approximately 9 million people developed the disease and 1.5 
million people died from it (WHO, 2014b). Infectious diseases are clearly a worrisome factor in human 
health. 
 
1.2. Challenges in the treatment of infectious diseases 
The health care sector implemented different strategies to eradicate infectious diseases, including the 
development of antibiotics, vaccines, improved hygiene and sanitation, and vector control. This 
improved the health of many people to such an extent that many people predicted the end of infectious 
diseases (Hamburg, 2008). However, factors such as an increase in international trade and travel, the 
movement of people to urban areas, reduced hygiene and sanitation in developing countries, among 
other factors, interfered with these management strategies, and resulted in the spread of infectious 
diseases. In recent times, a number of irresponsible practices, such unsafe sex and the careless use of 
syringes by drug addicts, also contribute to the widespread occurrence of infectious diseases 
(Hamburg, 2008). These problems are augmented by the development of resistant pathogens as well 
as difficulties with the accessibility and affordability of treatment.  Moreover, drugs that are currently 
available pose problems such as side effects; toxicity and high production costs (Kisangau et al., 2007; 
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Adwan et al., 2011; Rawat, 2012). The indiscriminate use of modern drugs or antimicrobial agents 
usually leads to the emergence of resistant pathogens that may cause nosocomial or hospital-acquired 
infections (Ibrahim et al., 2011; Daboor and Haroon, 2012).  
 
1.3. Drug-resistant pathogens  
Antibiotics were introduced into the health practice some years ago to combat infections or diseases 
(Hawkey, 2008). Antimicrobial agents such as penicillin, methicillin, streptomycin, vancomycin, 
chloroquine and many more have been a source of medication for years. However, during the past 
decades, we have witnessed a major increase in micro-organisms that developed multidrug resistance 
to antimicrobial agents (Oliphant and Eroschenko, 2015; Roca et al., 2015).  Multidrug-resistant 
pathogens can develop due to mutations that can take place even in the presence of antimicrobial 
agents. Another driving force that leads to resistance is found in the abuse or misuse of antimicrobials 
on patients and livestock, or the release thereof into the environment (Oliphant and Eroschenko, 2015). 
Resistance to penicillin and sulphonamides in particular was reported in the 1940s, followed by 
resistance to other antimicrobials (Jindal et al., 2015). The pathogens that currently indicate 
antimicrobial resistance include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumanii, Pseudomonas aeruginosa, Plasmodium falciparum, Enterobacter species and 
Mycobacterium tuberculosis (Boucher et al., 2009; Rice, 2008). In 2011b, WHO estimated that 
approximately 630 000 people were diagnosed with multidrug-resistant TB, and this affected 84 
countries (WHO, 2011b). Multidrug-resistant TB strains are responsible for 3.6% of all TB cases, and 
require two years of treatment using potentially toxic drugs such as floroquinolones and injectable 
aminoglycosides to replace the resisted Isoniazid (INH) and Rifampicin (RIF) (Winston and Mitruka, 
2012). Extensively drug-resistant strains are usually difficult or impossible to cure, and only a few 
countries are able to detect and isolate those strains (Goldberg et al., 2012).Two hundred and forty 
million infections and 860 000 deaths caused by malaria are recorded annually (WHO, 2010). Among 
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all the species that cause malaria, Plasmodium falciparum is the most severe species, and accounts for 
approximately 90% of all malarial infections in Africa (Lee et al., 2013). Malarial pathogens usually 
develop resistance to antimalarial drugs such as chloroquine and mefloquine, therefore increasing the 
number of deaths that occur as a result of malaria (Lee et al., 2013; Olliaro and Bloland, 2001). 
Community and hospital-acquired infections that are caused by methicillin-resistant Staphylococcus 
aureus are on the rise, and occur at an alarming rate, creating a major challenge for clinicians 
(Motamedi et al., 2010; Jindal et al., 2015). Shigella is another species that resists ciprofloxacin, which 
is the only recommended drug for Shigella-related infections (Jindal et al., 2015). Vancomycin-resistant 
Enterococci, Pseudomonas, Acinetobacter, antifungal-resistant fungi and antiviral-resistant viruses 
significantly increases the number of deaths that occur world-wide. They also contribute to the delay in 
the healing of patients who suffer infections (Jindal et al., 2015). It is for all these reasons that sources 
of drugs and drug leads should be found to overcome this major challenge posed by drug resistance. 
 
The problems associated with the antimicrobial drugs that are currently available have prompted the 
search for new antimicrobial remedies that are effective and present fewer problems (Obeidat et al., 
2012). Researchers have turned to natural sources such plants for solutions, and traditional medicinal 
plants are considered the best option (Adwan et al., 2011). 
 
1.4.  Plants and traditional medicine 
For thousands of years, people have relied on plants to meet their essential needs, such as the need 
for shelter, food, transport, clothing and medicine (Gurib-Fakim, 2006). Plants have been part of 
traditional medical systems for thousands of years, and they continue to supply people with remedies to 
treat various ailments (Normann and Snyman, 1996). Africa has diverse vegetation types, such as the 
tropical rain forests, coastal and alpines forests, savannas, woodlands and scrublands. In addition, 
Africa has diverse climatic and geographic factors that contribute to the survival of approximately 68 
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000 plant species (Cunningham, 1997). Tropical and subtropical Africa contains approximately 45 000 
plant species, of which 5 000 are medicinally used and contribute to 25% of the world trade in 
biodiversity (Iwu, 2014). Due to their availability and natural advantage, African people often use 
medicinal plants for their health care benefits, such as the treatment of colds, memory enhancement, 
immunity improvement, etc. (Dzoyen et al., 2013).  
 
It is estimated that approximately 70 – 95% of the world population in developing countries continue to 
rely on medicinal plants for the treatment of various diseases (Lewu and Afolayan, 2009; WHO, 2011a; 
Daughari, 2012). In South Africa, there is a rich tradition in the use of medicinal plants, which is based 
on approximately 3 000 species (Taylor et al., 2001), and approximately 60 – 80% of the country’s 
population depend on medicinal plants to meet their health care and psychological needs (Fuku et al., 
2013), this translates to approximately 27 million people (Mander, 1998; Street et al., 2008). People 
depend on medicinal plants to treat diseases, as it sometimes is the only system available in rural 
areas (Mabona and Van Vuuren, 2013). Challenges such as the remote location of health care centres 
and an inability to afford conventional/modern drugs make traditional medicine the first choice in rural 
areas. The use of traditional medicine is also attributed to the high accessibility of medicinal plants and 
traditional healers, the low toxicity thereof, the fact that it has less side effects, extensive local 
knowledge and the affordability thereof (Cheikhyoussef et al., 2011). However, there are indications 
that indigenous knowledge about medicinal plants is rapidly decreasing as modern education is 
increasing (Zerabruk and Yirga, 2012). Thus, there is an urgent need for the documentation of the use 
of medicinal plants in South Africa before this knowledge is lost forever (Masevhe et al., 2015). 
 
1.5.  The therapeutic potential of secondary metabolites 
Medicinal plants are known to contain secondary metabolites that present unlimited opportunities for 
identifying new drug leads as a result of their supreme chemical diversity (Cos et al., 2006; O'Bryan et 
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al., 2008). Secondary metabolites such as alkaloids, flavonoids, tannins, saponins, glycosides, etc. are 
usually found in plants where they fulfil a selective and survival function for the plants (Esterhuizen et 
al., 2006; Manimozhi et al., 2012). Secondary metabolites serve an important purpose for plants, as 
they protect plants from herbivores and microbial invasions, act as attractants for pollinators and  
seed-dispensing animals, and protecting plants from ultraviolet (UV) light (Gomez-Caracava et al., 
2014). Secondary metabolites are also responsible for the taste, odour and color of plants, and most of 
them have important applications in pharmacology, chemistry, agricultural and novel drug sectors 
(Cannes do Nascimento and Fett-Neto, 2010). Various secondary metabolites have the ability to 
indicate biological properties such as antimicrobial, antioxidant, anti-inflammatory, antifungal, antiviral 
and anthelmintic activities (Daboor and Haroon, 2012). The effectiveness of medicinal plants as 
therapeutic agents is established through the presence of these important bioactive constituents (Bedir 
et al., 2003; Bhat and Karim, 2010). The most important bioactive compounds in plants are alkaloids, 
flavonoids, tannins, phenols, glycosides and tannins (Kubmarawa et al., 2007). 
 
1.5.1. Polyphenolics 
Phenols are compounds that occur naturally as colour pigments that are responsible for the colour of 
fruits and vegetables. They are synthesised from the phenylalanine through the phenylalanine 
ammonia lyase (PAL) (Doughari, 2012). They fulfil important functions in plants, such as defence 
mechanisms against pathogens and herbivores, and thus can be considered as potential candidates for 
the management of pathogenic infections (Doughari, 2012). Polyphenolics with benefits for human 
health are phenolic acids, flavonoid polyphenolics (flavonones, flavones, xanthones and catechins), 
lignans and stilbenes (Hooper and Cassidy, 2006). The recent interest in polyphenolics is attributed to 
their beneficial effects on human health, such as their antioxidant properties. As a result, they are used 
to combat cancer and heart disease, and can sometimes be used as anti-inflammatory agents (Manach 
et al., 2004; Fraga et al., 2010; Barbehenn and Constabel, 2011). They were also reported to have 
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antimicrobial, antiviral, cytotoxic, and vasodilatory effects (Kuete et al., 2012; Kougan et al., 2013; 
Ngameni et al., 2013). 
 
1.5.2. Flavonoids 
Flavonoids are an important group of polyphenols that are present in many types of plants. They are 
structurally composed of more than one benzene ring (Kar, 2007) and over 4 000 flavonoids are known. 
They are the largest group of phenols, forming half of approximately 8 000 naturally occurring phenols 
(Harborne and Baxter, 1999). Flavonoids fulfil important functions in plants, such as flower and seed 
pigmentation; plant fertility and reproduction; and defence from UV light, predators and pathogens 
(Harborne and William, 2000). For many years, medicinal plants that contain flavonoids have been 
used to treat human diseases, and isolated flavonoids have also been found to perform important 
biological activities, such as antifungal and antibacterial activities (Havsteen, 2002; Cushnie and Lamb, 
2005). 
 
1.5.3. Alkaloids 
Alkaloids are usually found in higher plants, lower plants, insects, marine and micro-organisms (Kuete 
and Efferth, 2010; Wansi et al, 2013). Alkaloids are used as medication, as recreational drugs, or in 
entheogenic rituals. However, many of them are toxic, and can be used as toxins for weapons (Kuete et 
al., 2008). They are also used as anaesthetics, stimulants, psychedelics, analgesics, antibacterial 
agents, anticancer drugs, antihypertensive agents, spasmolysis agents, vasodilators, antiarrhythmia 
drugs, antiasthma therapeutics and antimalarials (Kuete and Efferth, 2010; Wansi et al., 2013; Zofou et 
al., 2013). 
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1.5.4. Tannins 
Tannins are the most abundant secondary metabolites in plants. They are known to have biological 
properties such as antifungal, antioxidant, anthelmintic, antidiarrhoeal and healing properties (Zuanazzi 
and Montanha, 2004). They are also known to defend plant leaves from insect herbivores by toxicity 
and deterrence (DeGabriel et al., 2009; Barbehenn and Constabel, 2011). Some types of tannins act on 
the arachidonic acid metabolism in leucocytes, which leads to the reversal of inflammation (Okuda, 
2005).  
 
1.5.5. Saponins 
Saponins are known for their soap-like properties when combined with water. They were named after 
Quillaja saponaria, a plant once used as soap (Doughari, 2012). Basically, saponins are produced by 
plants, marine animals and some bacteria. They are glycosides, synthesised from the mevalonic acid 
pathway via the isoprenoid pathway (Gomez-Caravaca et al., 2014). The first group of saponins 
consists of steroidal saponins common in monocotyledonous angiosperms, while the second group 
consists of triterpenoid saponins that are found in dicotyledonous angiosperms (Doughari, 2012). 
Saponins protect plants against attack by pathogens and herbivores (Augustin et al., 2011). They are 
therefore known to have antimolluscicidal, antidiabetic, antifungal, antiyeast, antibacterial, antimicrobial, 
antiparasitic, antitumoral and anti-inflammatory activity (Sparg et al., 2004; Elekofehinti, 2015). 
 
1.5.6. Terpenoids and steroids 
Terpenes are diverse volatile oily compounds that are derived from isoprene units. They are usually 
found in essential oils and resins, and include monoterpenes, diterpenes, triterpenes and 
sesquiterpenoids (Firn, 2010). Examples of monoterpenes include thujone, camphor, eugenol, menthol 
and terpinen-4-ol.  Diterpenes consist of taxols and resins and they are used as anticancer agents 
(Sandjo and Kuete, 2013). Triterpenes include steroids, sterols and cardiac glycosides. They possess 
© Central University of Technology, Free State
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properties such as anti-inflammatory, sedative and cytotoxicity activity (Chimene et al., 2013; Sandjo 
and Kuete, 2013). Sesquiterpenes such as betulinic acid, lupeol, oleanic acid and ursolic acid are 
known to have antimicrobial, antiplasmodial and neurotoxin properties. They act as irritants when 
applied on human skin and when consumed (Awoufack et al., 2013). Most of the terpenes have 
activities against cancer, malaria, inflammation and infectious diseases caused by viruses and bacteria. 
Terpene-based drugs, such as the anticancer drug Taxol and the antimalarial drug Artemisinin, were 
the most popular drugs; generating approximately US $ 12 billion in 2002 (Wang et al., 2005). Steroids 
are naturally occurring compounds that are produced biologically from terpenoid precursors. They have 
therapeutic action on cardiac muscles when injected into the human body (Firn, 2010). Hunters also 
use them as arrow poisons, indicating that cardiac glycosides should be used with caution, as 
excessive doses may cause death (Doughari, 2012).   
 
1.6.  Medicinal plants as a source of novel drugs 
The high rate of traditional medicine usage and the variety of indigenous plant species indicate much 
potential for the discovery of new bioactive compounds that can be used in the discovery of new drugs 
(Copp and Pearce, 2007). The interest in medicinal plants as potential new drugs is on the rise, and 
medicinal plants contribute 50% of all the drugs in the clinical world (Gurib-Fakim, 2006). The isolation 
of bioactive compounds from plants contributed to early discoveries of drugs such as aspirin, morphine, 
codeine, digoxin, atropine, quinine and artemisinin (Mueller et al., 2000; Samuelsson, 2004). Medicinal 
plants are considered the best option to overcome the challenges that are associated with the drugs 
that are currently available (Kaur et al., 2005). Table 1.1 illustrates some of the important drugs that 
were manufactured from plants.  
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Table 1.1: Plant-derived drugs 
Plant species Drug Use References 
Discorea spp Diosgenin Contraceptive Sarkar and Nahar, 
2007 
Rauwolfia sp Reserpine Antihypertensive Gurib-Fakim, 2006 
Pilocarpus spp Pilocarpin Treats glaucoma and dry 
mouth 
Gurib-Fakim, 2006 
Galanthus woronowii Galantamine Treats alzheimer’s disease Pirttila et al., 2004 
Artemisia annua Arteether Antimalarial  Graul, 2001 
Callistemon citrinus Nitisinone Treats tyrosinaemia Frantz, 2004 
  
1.7. Safety of medicinal plants 
Medicinal plants are usually preferred for medicinal purposes, as they are presumed to have fewer side 
effects and are regarded as safer to use than conventional drugs. However, some species are known to 
be toxic to humans (Ndhlala et al., 2013). The toxicity of plants is usually attributed to the presence of 
compounds that can contribute to the survival of plants. Toxic plants can cause irritation or discomfort 
through skin contact, and serious poisoning when indigested (Van Wyk et al., 2002). Serious poisoning 
by plants may cause damage to major organs such as the brain, kidneys, central nervous system, 
lungs and the liver (Ndhlala et al., 2013). Humans have managed to use the toxicity of plants to their 
benefit for purposes of hunting, war, rituals, murder, suicide and abortion (Doughari, 2012; Ndhlala et 
al., 2013). The fast-acting cardiac glycosides such as Acokanthera, Boophone, Strophanthus and 
Adenium were used by San hunters in Southern Africa to create poisoned arrows (Wink and Van Wyk, 
2008). Some poisonous phytochemicals such as saponins (Kar, 2007), alkaloids, phorbol esters, lectins 
and cyanogenic glycoside possess medicinal properties at lower concentrations (Ndhlala et al., 2013). 
© Central University of Technology, Free State
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Despite the toxicity that cardiac glycosides possess, western doctors still prescribe digoxin from genus 
Digitalis for patients with congestive heart failure. This practice indicates that toxic plants may be used 
to treat ailments; however, they should be used with caution by regulating the dosage to be 
administered to a patient to avoid lethal side effects (Botha and Penrith, 2008).  
 
1.8.  The plants used in this study 
Plants such as Buxus macowanii (B. macowanii), Polygala myrtifolia (P. myrtifolia), Scilla sp. and 
Xanthocercis zambesiaca (X. zambesiaca) are traditionally used to treat different ailments. Methanolic 
extracts from these plants were supplied by the Alternative Crop Development Programme of the 
University of the Free State (UFS), Bloemfontein, for use in this study. 
 
1.8.1.  Buxus macowanii Oliv. 
B. macowanii (Figure 1.1) is commonly known as a “Cape Box”. In Xhosa it is called “Umgalagala” or 
“Igalagala” (Pooley, 1993). It belongs to the family Buxaceae, which contains four genera and 
approximately 100 species (Glen, 1996). It is a small-growing, evergreen plant that is found in the 
Eastern Cape, Mpumalanga and Limpopo provinces of South Africa. This plant is commonly used by 
traditional healers to treat wounds, pain, gout, malaria, rheumatism and skin disorders (Wink and Van 
Wyk, 2008). Plants from the genus Buxus are rich in steroidal alkaloids (Ata and Andresh, 2008). Lam 
et al. (2015) reported the isolation of five new steroidal alkaloids (31-hydroxybuxatrienone, 
macowanioxazine, 16a-hydroxymacowanitriene, macowanitriene and macowamine) along with another 
five known steroidal bases (Nb-demethylpapillotrienine, moenjodaramine, irehine, buxbodine B and 
buxmicrophylline C). These aforementioned steroidal alkaloids were reported as having moderate to 
weak anti–Acetylcholinesterase activity (Rosenbery, 1975; Ata, 2012). 
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Figure 1.1: Buxus macowanii Oliv. 
 
1.8.2.  Polygala myrtifolia L.  
The Polygala genus belongs to the family Polygalaceae, which contains approximately 600 species 
(Fenner et al., 2005). P. myrtifolia (Figure 1.2), commonly known as “Myrtle milkwort” is a leafy 
perennial shrub usually found in South Africa’s coastal and elevated environments between Cape Town 
and KwaZulu-Natal. Chemical investigation of the genus Polygala indicated the presence of secondary 
metabolites such as xanthones (Cristiano et al., 2003), saponins (Jia et al., 2004; Mitaine-Offer et al, 
2003), oligosaccharides (Ikeya et al., 2004), flavonoids (Rao and Raman, 2004; Pizzolatti et al., 2008), 
coumarins, and styryl pyrones (Pizzolatti et al., 2004). Different biological activities were found on 
various species of Polygala genus, such as antibacterial, anti-inflammatory, trypanocidal and 
antinociceptive, antifungal and antimycobacterial activity (Lall and Meyer, 1999;  Motsei et al., 2003; 
Pizzolatti et al., 2003; Kou et al., 2006; Pizzolatti et al., 2008; Ribas et al., 2008).  
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Figure 1.2: Polygala Myrtifolia L. 
 
1.8.3. Xanthocercis zambesiaca (Baker) 
Fabaceae is the third largest family of Angiosperms, consisting of more than 700 genera and 
approximately 2 0000 species of trees, vines and shrubs world-wide (Stevens, 2001). The family 
contains approximately 490 medicinal species that are used in traditional medicine (Gao et al., 2010). 
The boiled stem and roots of X. zambesiaca (Figure 1.3), also known as “Umhlwati”, are used by 
traditional healers to treat stomach complaints and “Nyoko”, an impairment of the gall bladder (Shai et 
al., 2011). The acetone extracts of X. zambesiaca were reported to have antimycobacterial activity 
(Mmushi et al., 2010). Ntsoelenyane et al. (2014) also reported antibacterial activity of the methanol 
extracts of the plant. 
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Figure 1.3: Xanthocercis zambesiaca (Baker) 
1.8.4. Scilla Species 
The genus Scilla sp. belongs to the Hyacinthaceae family and Scilloideae subfamily. Species in 
Hyacinthaceae are known to treat diseases such as urinary diseases, gastrointestinal problems, 
respiratory problems, headaches, swelling and skin problems, and they are used as internal purifiers 
(Hutchings., 1996; Louw et al., 2002). Members of this family are known to have traces of 
phytochemicals such as saponins and homoisoflavanones. However, the presence of alkaloids and 
steroids in some species may indicate cytotoxicity (Speta, 1998).  
 
1.9.  Aims and objectives 
The aim of the study was to evaluate the antimicrobial activity of Buxus macowanii, Scilla sp., Polygala 
myrtifolia and Xanthocercis zambesiaca. This was achieved by meeting the following objectives: 
 Determining the antimicrobial activity of methanol extracts from Buxus macowanii, Polygala 
myrtifolia, Scilla sp and Xanthocercis zambesiaca. 
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 Locating the antimicrobial compounds using Thin Layer Chromatography (TLC). 
 Examining the effect of the plant extracts on the microbial cells using Scanning Electron 
Microscopy (SEM) and Transmission Electron Microscopy (TEM). 
 Determining the phytochemical content of Buxus macowanii, Polygala myrtifolia, Scilla sp. and 
Xanthocercis zambesiaca; and 
 Evaluating the cytotoxicity of the methanol extracts of Buxus macowanii, Polygala myrtifolia, Scilla 
sp. and Xanthocercis zambesiaca. 
 
1.10. Overview of the study 
This study is presented in four sections. In Chapter 2, the antimicrobial activity of the plant extracts was 
evaluated using the microdilution method, TLC bioautography and microscopy. The cytotoxicity of the 
extracts was tested using the Sulforhodamine B cytotoxicity assay (SRB), the results of which are 
discussed in Chapter 3. Chapter 4 focused on the determination of the phytochemical contents of the 
plant extracts using the standard phytochemical screening methods, TLC and Gas Chromatographic 
Mass Spectrometry (GCMS). Chapter 5 provides general discussions of the results obtained in this 
study, conclusions and recommendations. The techniques and procedures used to evaluate the 
antimicrobial activity of B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca are illustrated in Figure 
1.4.  
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CHAPTER 2 
ANTIMICROBIAL ACTIVITY OF BUXUS MACOWANII, POLYGALA MYRTIFOLIA, SCILLA SP AND 
XANTHOCERCIS ZAMBESIACA 
 
2.1. Introduction 
The use of western medicine to treat infectious diseases has always been associated with a number of 
problems that make the treatment of infectious diseases more challenging. The use of antimicrobial 
drugs that are currently available include problems such as limited accessibility for people living in rural 
areas or places remote to health care facilities, high purchase prices, and side effects (Bodeker and 
Graz, 2013). The emergence of drug-resistant pathogens and an increase in opportunistic infections in 
people with HIV/AIDS and those receiving chemotherapy are additional problems that make the 
treatment of infectious diseases very difficult (Fargana et al., 2014). These problems have encouraged 
researchers and scientists to devise new alternative manners of treatment, which can lead to the 
discovery of novel drugs that will overcome the challenges associated with the drugs that are currently 
used. 
 
For thousands of years, plants have been used by millions of people as a source of food and for 
medicinal purposes (Brouwer et al., 2005). An estimated 80% of the world’s population, and 72% of 
black South Africans, still rely on traditional medicine for their primary health care needs (Gurib-Fakim, 
2006). Traditional medicine has not only gained popularity due to its effectiveness against diseases, but 
because it is sometimes the only available system in rural areas (Mabona and Van Vuuren, 2013). The 
use of traditional medicine is further attributed to advantages such as accessibility, affordability, fewer 
side effects, and extensive knowledge and expertise thereof by people within communities (Fennell et 
al., 2004; Runyoro et al., 2006).  
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Medicinal plants, especially those used by traditional healers, have become the focus of research, and 
are considered as the best option for the production of novel drugs, as they have an unmatched 
chemical diversity (Cos et al., 2006; O’Bryan et al., 2008). They contain bioactive compounds such as 
alkaloids, terpenoids, tannins, flavonoids, peptides and phenolic compounds that are known to have 
antimicrobial, antiviral, antifungal, anti-inflammatory, anthelmintic and antioxidant activity (Kubmarawa 
et al., 2007). Moreover, medicinal plants are known to work on different target sites than those targeted 
by conventional drugs (Kimberlin and Whitley, 1996). They are also cheaper and have fewer side 
effects, and thus medicinal plants remain an important and better alternative source from which new 
therapeutic agents can be manufactured. 
 
Traditional knowledge and ethnobotany help researchers to identify medicinally relevant plants that can 
lead to the discovery and manufacturing of new drugs. Available literature indicated that plants such as 
B. macowanii, P. myrtifolia, X. zambesiaca and other Scilla sp. are traditionally used for the treatment of 
wounds, skin disorders, stomach problems, back problems, fractures and other major diseases, such 
as cancer (Pooley, 1993; Hutchings et al., 1996; Crouch et al., 1999, Shai et al., 2011). It is therefore 
necessary that this chapter focuses on studying the antimicrobial activity of these plants, and the 
minimum concentration at which the extracts inhibit the growth of bacteria and fungi, by using the 
microdilution method.  
 
2.2. Methods 
2.2.1. Plant extracts 
Buxus macowanii Oliv (Buxuceae), Polygala myrtifolia L. (Polygalaceae), Scilla sp. (Asparagaceae) and 
Xanthocercis zambesiaca (Baker) (Fabaceae) were selected for the investigation of their antimicrobial 
activity against bacterial and fungal species. Methanol plant extracts and information about the plants 
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(as presented in Table 2.1) were supplied by the Department of Soil, Crop and Climate Sciences at the 
University of the Free State (UFS) because they were the only type of extracts available. 
 
Table 2.1. Information about plant extracts  
Plant name Plant part Collection 
number 
Extract 
number 
Place of collection 
B. macowanii Oliv Leaves and twigs RB 829 a  
(Brand 795) 
1544 Mpumalanga 
Scilla sp. Whole plant RB 512  
(Brand 614) 
1272.2 Eastern Cape 
Scilla sp. Roots and bulbs JV 9852b  
(Venter 251) 
1163 Free State 
P. myrtifolia L Leaves and twigs RB 801 a  
(Brand 753) 
1561 Eastern Cape 
X. zambesiaca 
(Baker) 
Stem  
               - 
1584 Mpumalanga 
 
2.2.2. Extract preparation and storage 
The plants were collected, washed, oven dried at 40ºC for 72 hours, and ground to powder. The dry, 
powdered material of the plants was extracted with 100% methanol because the solvent is easy to 
evaporate and does not affect results of any screening. The methanol was evaporated at 40ºC, under a 
vacuum, using a Buchi Rotavapor. All extracts were stored in the fridge at -20ºC until required (Zaidan 
et al., 2005). 
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2.2.3. Microbial cultures 
The antibacterial activity of the plant extracts was evaluated against Staphylococcus aureus (ATCC 
25923), Clostridium perfringens (ATCC 13126), Pseudomonas aeruginosa (ATCC 27853), 
Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922) and Staphylococcus epidermidis 
(ATCC 12228). The fungal species used were Candida albicans (ATCC 90028) and Candida tropicalis 
(ATCC 756). Bacillus cereus (ATCC 13061) was selected for examination of the cell wall after treatment 
with the plant extract, which exhibited the best antibacterial activity using microscopy. All the bacterial 
and fungal species were supplied by the National Health Laboratory Services, Bloemfontein, South 
Africa. All the microbial species were maintained in Mueller Hinton agar plates at temperatures of 4ºC. 
Prior to treatment with the plant extracts, the bacteria were inoculated in Mueller Hinton broth, and 
incubated and shaken at 100 revolutions per minute (rpm) for 24 hours, to ensure purity and viability. 
Thereafter, one millilitre of the culture was diluted in 100 ml of Mueller Hinton broth (1:100) (Meyer and 
Afolayan, 1995). 
 
2.2.4. Antimicrobial activity 
The antibacterial and antifungal activity of five plant extracts was investigated using the microdilution 
method developed by Eloff (1998). The microdilution method was selected because it is easier to 
perform, and it can determine the minimum inhibitory concentration of plant extracts, as opposed to the 
agar diffusion method. One hundred microliters of the bacterial suspension was pipetted into the 96 
microwell plates already containing 100 µl of diluted plant extract to make a final volume of 200 µl in 
each well. The concentration of the plant extracts ranged from 0.16 mg/ml to 2.5 mg/ml. The control 
wells were respectively filled with culture medium only, bacterial suspension, 5% dimethyl sulfoxide 
(DMSO) (Nostro et al., 2000; Baris et al., 2006), and plant extract only. Chloramphenicol (0.125 mg/ml) 
was used as a positive control in bacteria, while amphotericin B (0.03-1 µg/ml) was used in fungi 
because it is one of the antifungal agents that were used to treat fungal infections (Wanger et al., 2005; 
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Andrews, 2001). The microwell plates were incubated for 24 hours, where after 40 µl of 4 mg/ml 
Iodonitrotetrazolium salt solution was added to each well. Growth was indicated by a change of colour 
ranging from pink to violet after 10 to 30 minutes’ incubation. All samples were tested in triplicates. The 
minimum inhibitory concentration (MIC) was recorded as the lowest concentration at which the plant 
indicated bacterial or fungal growth inhibition. 
 
2.2.5. Thin Layer Chromatography (TLC) bioautography  
The bioautography method was used to screen and identify compounds with antibacterial activity 
present in the plant extracts of B. macowanii. The detection of antimicrobial compounds was performed 
using aluminium-coated DC-fertigfolien alugram Xtra Sil G/ Uv 254 TLC plates. The plant that exhibited 
the best antibacterial activity was loaded onto three TLC plates, and eluted using a mobile polar solvent 
system Toluene, Chloroform and Ethanol (5.7:11.4:2.9), which provided the best separation of the 
compounds. The developed plate was left to dry for 24 hours to remove traces of the solvent on the 
plate. The prepared TLC plate was sprayed with the Enterococcus faecalis bacterial suspension until 
wet, whereafter it was incubated overnight at 37ºC and at 100% relative humidity for 8 hours 
(Esterhuizen et al., 2006). The plate was sprayed with 4 mg/ml solution of Iodonitrotetrazolium chloride, 
and further incubated for eight hours in a sealed container for colour development. The antibacterial 
compounds were identified as white areas against a violet- or pink-coloured background, which 
indicated bacterial growth. On the other two plates, the separated alkaloids were detected using 
Dragendorff’s reagent, and flavonoids were detected using natural product-polyethylene glycol reagent. 
The detected alkaloids and flavonoids were visualised under ultraviolet light at a wavelength of 365 nm. 
All the TLC plates were run in duplicates, and one was used as a reference chromatogram.  
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2.2.6. The microscopic analysis of the bacterial cell wall. 
The effect of B. macowanii on bacterial morphology was examined using scanning and transmission 
electron microscopy. B. cereus was treated with different concentrations (0.2 to 2.5 mg/ml) of the 
methanol extracts of B. macowanii. The untreated samples (control) and the treated samples were 
incubated at 37ºC for 24 hours. After incubation, the cells were washed twice with 0.1 M phosphate 
buffer solution (PBS, pH 7.0), were subjected to fixation using 3% glutardialdehyde and 1% 
osmiumtetroxide, and were kept for two hours at -4ºC. Thereafter, fixation of the cells were further 
subjected to dehydration in ethanol at successive concentrations of 50%, 70%, 95% and 100%, 
followed by critical point-drying using Carbon dioxide (CO2) to remove the ethanol. The samples were 
finally mounted on a specimen stub and coated with gold under vacuum, followed by microscopic 
examination using SEM (Moosavy et al., 2008; Lv et al., 2011). For TEM-dehydrated bacterial cells, 
cells were embedded by replacing ethanol with epoxy to make slim sections suitable for microscopic 
examination. Samples were further embedded using epoxy for eight hours at 70ºC in a special mould. 
The samples were cut into sections using ultramicrotome, and were stained with 6% Uranyl and lead 
citrate, followed by TEM examination (Joshi et al., 2010; He et al., 2014). 
 
2.3. Results and discussion 
2.3.1. The antimicrobial activity of the selected plant extracts 
P. myrtifolia, Scilla sp. and X. zambesiaca showed no activity against all the microbial strains against 
which they were tested. Previous studies documented antimicrobial activity of X. zambesiaca (Mmushi 
et al., 2010; Masoko, 2013) and antifungal activity of P. myrtifolia (Motsei et al., 2003). A factor such as 
the choice of solvent might have affected the antimicrobial activity of extracts from X. zambesiaca and 
P. myrtifolia, because bioactive phytochemicals are affected by factors such as solvent polarity. The 
extracts of B. macowanii showed antimicrobial activity against S. aureus, S. epidermidis, C. albicans, C. 
tropicalis, C. perfrengens and P. aeruginosa, where the minimum inhibitory concentration (MIC) was 2.5 
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mg/ml. B. macowanii also showed antimicrobial activity against E. faecalis and E. coli (MIC:1.2 mg/ml). 
Usually one may expect a variation in the inhibitory activity against Gram-negative and Gram-positive 
bacteria due to their differences in cell wall composition; however, it was found that both bacteria were 
affected in the same way. The inhibition of Gram-negative bacteria, Gram-positive bacteria and 
Candida is therefore of critical importance, because of their drug resistance to current antibacterial and 
antifungal agents. The B. macowanii’s inhibitory activity against Gram-negative bacteria, Gram-positive 
bacteria and Candida may indicate a possible breakthrough in the fight against the challenges caused 
by drug-resistant micro-organisms. Numerous studies have reported that most species in the Buxus 
genus are a rich source of steroidal alkaloids. It can be suggested that the antimicrobial activity B. 
macowanii extracts can be attributed towards alkaloids, which, according to literature, are abundantly 
found in most plants that belong to the Buxus genus (Loru et al., 2000; Atta-ur-Rahman, et al., 2001; 
Babar et al., 2006; Ata and Andresh, 2008). Thus B. macowanii was considered the best option for 
further investigation. 
 
2.3.2. TLC bioautography 
Antimicrobial compounds from the extracts of B. macowanii were identified using the TLC 
bioautography. The clear zones on the TLC chromatogram indicated that the extracts of B. macowanii 
contain compounds that have antibacterial activity against E. faecalis using a solvent system of 
Toluene, Chloroform and Ethanol (5.7:11.4:2.9) (Figure 2.1). Four clear zones were identified on the 
bioautography chromatogram, suggesting that the antibacterial activity of B. macowanii cannot only be 
attributed to one compound. A yellowish-orange colour under visible light showed that the extracts of B. 
macowanii have alkaloids, as indicated in Figure 2.2. Figure 2.3 showed traces of flavonoids in B. 
macowanii by a dark yellow, green or blue fluorescence colour under UV light at a wavelength of 354 
nm. Some studies reported over 200 or more steroidal alkaloids isolated in various species belonging to 
the genus Buxus (Ata et al., 2002; Meshkatalsadat et al., 2006; Babar et al., 2006; Ata et al., 2010; 
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Matochko et al., 2010). Flavonoids have also been reported to have antibacterial and antifungal 
properties (Manimodzi et al., 2012). Therefore, the presence of alkaloids and flavonoids may explain 
the antibacterial effects of B. macowanii. 
 
                                                  
 
Figure 2.1: Chromatogram developed with Toluene/Chloroform/Ethanol (5.7:11.4:2.9) indicates the 
antibacterial activity of the plant B. macowanii against E.faecalis. 
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Figure 2.2: A chromatogram developed with Toluene/Chloroform/Ethanol (5.7:11.4:2.9) indicates the 
presence of alkaloids in the extracts of Buxus macowanii. An orange colour indicates the presence of 
alkaloids. 
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Figure 2.3: A chromatogram developed with solvent system Toluene/Chloroform/Ethanol (5.7:11.4:2.9) 
indicates the presence of flavonoids in the extracts of Buxus macowanii under UV light. A green-blue 
colour indicates the presence of flavonoids. 
 
2.3.3. The effect of Buxus macowanii on the cell morphology 
The effect of the extracts of B. macowanii on the bacterial cell morphology was examined using 
Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM). SEM was used to 
examine the morphology of the cells of Bacillus cereus treated with extracts of B. macowanii, for 24 
hours at 37ºC. The untreated samples of B. cereus were considered as a control. Under normal 
conditions, the cells of B. cereus under a microscope appear as long bacilli cells (Figure 2.4 (A)). The 
cells of B. cereus that were treated with the extracts of B. macowanii at the MIC concentration of 2.5 
mg/ml in SEM showed major structural changes compared to the untreated cells that lead to cell death 
(Figure 2.4 (B) and (C)). Figure 2.4 (C) indicates some damage to cell walls (DCW), which is evident by 
holes on the surface of the cell. The extracts also caused incomplete cell division (ICD), and 
swollenness of the cells (SC), caused by the penetration of the plant extracts into the cell. The swelling 
of the cell lead to cytoplasmic membrane damage, which eventually resulted in loss of the intracellular 
contents (LCC), which were observed outside the cells. The loss of cellular or cytoplasmic contents 
resulted in shrinkage of the cell (SC), which was explained by the wrinkled surface of the cell (Figure 
2.4 (B) and (C)). The effects of B. macowanii on the morphology of the bacterial cells also 
demonstrated some damage in the structure of the cells because treated cells examined using TEM 
showed cell-wall distortion, which resulted in increased membrane permeability (Figure 2.5(B)). When 
cell-membrane permeability increased, the loss of intracellular or cytoplasmic contents occurred. 
Incomplete cell division, roughness of the cell and separation of the cytoplasmic membrane from the 
cell wall were some of the morphological changes that were caused by the extracts of B. macowanii on 
the bacterial cells. Vancomycin is one of the drugs that are used to treat infections that are caused by 
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Bacillus cereus.  It usually inhibits the second stage of cell-wall synthesis, alter the cell-membrane 
permeability, and inhibits ribonucleic acid synthesis (Watabakunakorn, 1981). Given the results that 
were obtained via SEM and TEM, B. macowanii was identified as the best treatment and may be the 
best option for the development of a new drug that can control resistant pathogens causing infectious 
diseases.1 
                                                          
 
 
1 This section has been submitted for publication with the title: Antimicrobial activity of Buxus macowanii 
and its morphological effects on Bacillus cereus. (See annexure B). 
© Central University of Technology, Free State
© Central University of Technology, Free State
© Central University of Technology, Free State
40 
 
chromatogram. Further analysis using a solvent such as diethylamine to achieve an ideal separation of 
compounds and direct isolation of antimicrobial compounds, is recommended. 
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CHAPTER 3 
THE IN VITRO CYTOTOXICITY OF BUXUS MACOWANII, SCILLA SP., POLYGALA MYRTIFOLIA 
AND XANTHOCERCIS ZAMBESIACA 
 
3.1. Introduction 
Most indigenous medicinal plants in Africa are still widely used in unprocessed form, without any 
scientific validations for the safety and efficacy thereof (Fennell et al., 2004; Ndhlala et al., 2013). There 
are approximately 1 000 known poisonous plant species, containing 750 poisonous substances, which 
occur in 150 000 plant secondary metabolites (Wink and Van Wyk, 2008). When traditional medicine is 
used for the treatment of ailments, misidentification, incorrect preparation and incorrect dosage may 
result in poisoning (Fennel et al., 2004). Poisoning is common in South Africa, and it is estimated that 
approximately 8 000 to 20 000 deaths occur from poisoning on an annual basis. The forensic database 
for Johannesburg revealed that, from 1991 to 1995, 43% of poisoning resulted from the usage of 
traditional medicine (Thomson, 2000). The current rate of mortality is expected to be higher moreover; 
most of the cases remain unrecorded, as the use of traditional medicine is usually kept secret (Stewart 
and Steenkamp, 2000; Thomson, 2000). 
 
Plants that are used as traditional medicine have and are still presumed to be safe to use in any way, 
as they have been used for the treatment of different ailments for a long time. However, research 
indicates that most plants that are used as traditional medicine or food are potentially toxic, mutagenic 
and carcinogenic (Kassie et al., 1996; De Sa Ferrira and Ferrao Vargas, 1999). The toxicity of plants is 
attributed to the concept that plants produce compounds or substances that prevent infections by 
bacteria and viruses but at the same time these substances can be toxic to humans, even when 
consumed in small quantities (Wink and Van Wyk, 2008). Secondary metabolites, such as alkaloids, 
saponins, terpenes, phenolic compounds and many more of these compounds that have human health 
benefits, can also be poisonous. 
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Saponins are known to have hypolipidemic and anticancer activity; however, they can cause toxic 
effects such as haemolysis and cattle poisoning (Kar, 2007). Alkaloids are known to have antibacterial, 
anticancer, antimalarial, antiasthma and antiarrhythmia activity, but higher doses can cause death, 
cardiac or respiratory arrest, mutations, and even cancer (Wink, 2009; Kuete and Efferth, 2010; Wansi 
et al., 2013). Phenolic compounds such as hydroquinone have shown mutagenic potency, while natural 
phenolics have been reported to have antimicrobial, antioxidant, antiviral, anti-inflammatory and 
vasodilatory effects (Roza et al., 2003; Chen et al., 2010). With the forementioned compounds present 
in most of the plants that are used in traditional medicine, it is unsafe to assume that these plants can 
be used for the treatment of diseases without regulatory measures.  
 
Punica granatum L. has been used to enhance fertility, but if used without any regulations, it can be 
toxic, causing disturbances in vision, spasms, nausea, vomiting, gastroenteritis, convulsions and death 
(Wink and Van Wyk, 2008; Lee et al., 2010). The leaves of the Aloe ferox can be used as a laxative 
and emetic; for the relief of arthritis, sinusitis, conjunctivitis and opthalmia for healing skin and wounds; 
and in the treatment of sexually transmitted infections. However, the plant can also cause intestinal 
bleeding, enhanced menstrual and uterus bleeding, kidney disturbance, and hypertrophy of intestinal 
tissues (Kambizi et al., 2007; Wink and Van Wyk, 2008). 
  
Plants such as B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca are often used for the 
treatment of different ailments, but information about their toxic effects on human cells, mode of 
administration, and administration dosages is scarce. It is against this background that the cytotoxicity 
of extracts from these plants was studied. In this chapter, the cytotoxicity of B. macowanii, P. myrtifolia, 
Scilla sp. and X. zambesiaca against WI-38 (normal fetal lung fibroblast cells) is presented using the 
Sulforhodamine cytotoxicity assay. 
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3.2. Methods 
3.2.1. Extracts of B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca were prepared in the same 
manner described under 2.2.2 in Chapter 2 (see page 29). 
  
3.2.2. The Sulforhodamine cytotoxicity assay 
The Sulforhodamine B (SRB) assay was conducted to evaluate the toxicity of the extracts of B. 
macowanii, Scilla sp., P.myrtifolia and X. zambesiaca against the WI-38 (normal human fetal lung 
fibroblast) cell line, as described by Itharat et al. (2004). The method is based on the ability of the 
protein dye Sulforhodamine B to bind electrostatically to (Potential hydrogen) pH dependent protein-
basic amino acid residues of trichloroacetic acid-fixed cells. The WI-38 cell line from the European 
Collection of Cell Culture (ECACC) were maintained at 37ºC, 5% carbon dioxide CO2, 95% air and 
100% relative humidity as a monolayer cell culture in Eagle’s Minimal Essential Medium (EMEM), 
supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine and 50 µg/ml gentamicin. For 
screening processes, the cells (21-50 passages) were inoculated in 96-well microtiter plates at a plating 
density of 10 000 cells/wells, and incubated for 24 hours. After 24 hours, the cells were treated with the 
plant extracts at five different concentrations, ranging from 6.25 to 100 µg/ml (five x two-fold serial 
dilutions), and were incubated for another 48 hours (Skehan et al., 1990). The untreated cells served as 
a control, the blank contained the medium without cells, and etoposide was used as a standard at 
concentrations ranging from 100 µg/ml to 0.05 µg/ml (eight x three-fold serial dilutions) (Wellington and 
Kolesnicova, 2012). After 48-hours incubation, viable cells were fixed to the bottom of each well with 
50% cold trichloroacetic acid, washed, dried and dyed by SRB. The protein-bound dye was removed 
with 10 mM Tris base, and the optical density determined at a wavelength of 540 nm, using a multiwell 
spectrophotometer. The IC50 was considered as the 50% cell growth inhibition, and it was determined 
by non-linear regression. GraphPad Prism software was used to perform data analysis and create the 
graphs.  
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3.3. Results and discussion 
The bulb, roots and entire plant extracts of Scilla sp. showed toxicity against the human fetal lung 
fibroblast cells, with an IC50  less than 6.25 µg/ml, even at lower concentrations. The extracts decreased 
the viability of the normal fetal fibroblast cell (Table 3.1.). These results correlate with the results 
published by Sparg et al. (2000), who confirmed that Scilla natalensis, which belongs to the Scilla 
genus, was cytotoxic, and should be used with caution as herbal medicine. The toxicity can be 
attributed to the presence of steroids, cardiac glycosides and alkaloids (Van Wyk et al., 1997). 
According to Council for Scientific and Industrial Research (CSIR) criteria, the extracts of B. macowanii 
showed moderately hazardousness against the WI-38 cell line, as they showed an IC50 of less than 30 
µg/ml and greater than 5 µg/ml. As indicated by the graph in Table 3.1, results confirmed that the 
extracts of B. macowanii had lower toxicity at lower concentrations, but proved to be toxic at higher 
concentrations, as the cell viability increased to 50% at 20.4 µg/ml. A number of articles have reported 
that plants belonging to the Buxus genus have an abundance of steroidal alkaloids (Loru et al., 2000; 
Atta-ur-Rahman et al., 2001). The steroidal alkaloids found in B. macowanii were indicated to have 
various biological properties such as anti-Human Immune Virus (HIV), antimalarial, anti-Tuberculosis 
(TB) properties, to mention only a few (Babar et al., 2006; Ata and Andersh, 2008). Despite the fact that 
alkaloids can be associated with the aforementioned good biological properties, it has been reported 
that alkaloids can be toxic to humans and animals; therefore caution must be taken in consumption 
(Allgaier and Franz, 2015). X. zambesiaca showed moderately hazardousness at a concentration of 
22.96 µg/ml, whereas P. myrtifolia exhibited low toxicity against the WI-38 cell line, as the cell viability 
did not decrease as the concentration of the extract increased, therefore, it can be suggested that P. 
myrtifolia is safer to use. 
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Table 3.1: The IC50 of plant extracts of B.macowanii, Scilla sp., P.myrtifolia and X.zambesiaca 
 
Plant extract IC50 (µg/ml) Cytotoxicity 
Etoposide (standard) 5.1 
 
Buxus macowanii 20.4 
 
Scilla sp. (bulb and roots) 
<6.25  
Scilla sp. (entire plant) 
<6.25  
P. myrtfolia 22.96 
 
X. zambesiaca >100 
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3.4. Conclusion 
This chapter investigated the toxicity of different plant extracts of B. macowanii, P. myrtifolia, Scilla sp. 
and X. zambesiaca. With many people relying on plants as traditional medicine for their health care, 
toxicity to humans is one of the major factors that must be taken into consideration. The above-
mentioned plant extracts are usually used in traditional medicine to treat ailments without hospital 
supervision; therefore, it was necessary to highlight or investigate their toxicity to human cells. Although 
plants such as Scilla, B. macowanii and X. zambesiaca have been highlighted as toxic to WI-38, it does 
not mean their use should be prohibited. Rather, care should be taken in their consumption. Structure-
related activity studies and chemical-modification experiments that will reduce toxicity and maintain 
activity of the plant extracts can be employed, confirming that these plants are the best candidates in 
manufacturing of new alternative drugs.  
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CHAPTER 4 
PHYTOCHEMICAL CONTENT OF THE EXTRACTS OF B. MACOWANII, P. MYRTIFOLIA, SCILLA 
SP. AND X. ZAMBESIACA 
 
4.1. Introduction 
Plants produce a large number of bioactive compounds of selective and survival importance. These 
bioactive compounds possess important therapeutic properties for use in the treatment and 
management of diseases by producing physiological actions in the human body (Mitscher et al., 1987; 
Reayi and Arya, 2005; Edeoga et al., 2005; Akinpelu et al., 2008). Recently, there is great interest in 
medicinal plants, as the pharmaceutical industry considers them as a great option in the provision of a 
large number of leads that are essential in the production of new drugs (Soejarto, 1999). 
 
The most important bioactive compounds in plants are alkaloids, tannins, saponins, flavonoids, steroids 
and phenolic compounds (Hill, 1952; Kubmarawa, 2007). Plants containing such bioactive compounds 
are usually used by traditional healers, and are known to have antimicrobial, anthelmintic, antiviral, 
antifungal, anti-inflammatory and antioxidant activity (McGaw et al., 2000). Alkaloids made up of 
ammonia compounds, containing a nitrogen base, are the largest group of secondary metabolites 
(Doughari, 2012). There are more than 12 000 alkaloids that exist or are present in approximately 12% 
of plant species. In combination with vegetable acids, alkaloids are usually present in the seeds and 
roots of plants. Alkaloids make up most of the drugs used pharmacologically as anaesthetics and 
central nervous system (CNS) stimulants (Madziga et al., 2010).  
 
Other important chemical compounds are polyphenols that are responsible for the pigmentation and 
protection of plants from herbivores and pathogens. Polyphenolics are used in the control of human 
pathogenic infections, and as antioxidants and anticancer agents (Kar, 2007). Secondary metabolites, 
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such as flavonoids, are an important group of polyphenols. They are made of C15 aromatic 
compounds, and traces of them are usually found in many plant flora (Doughari, 2012). They have 
been recognised as having a protective effect against microbial invasion in plants, which could explain 
their positive effect in protecting humans from microbial invasion (Horborne and William, 2000; 
Doughari, 2012). Isolated flavonoids are known to possess biological activities such as antifungal and 
antibacterial activities (Sathiamoorthy et al., 2007). Terpenes are another important class of secondary 
compounds that are made from isoprene units. They can occur as monoterpenes, diterpenes, 
triterpenes, tetraterpenes and sesquiterpenes. Terpenes have important biological activities, such as 
antimicrobial activities, against Candida species (Alves et al., 2013). Other secondary metabolites with 
antimicrobial activity include phenols and steroids; further indicating the potential of plants and their 
phytochemicals in the treatment of infectious diseases.  
 
The contribution of plants in the fight against diseases is indicated by the fact that an estimated 25% of 
prescribed drugs world-wide are manufactured from plants (Gurib-Fakim, 2006). Examples of 
antimicrobial drugs that were manufactured from plants include the fluoroquinolone and quinolone 
antibiotics that are used to control malaria, which were derived from alkaloid quinine that was isolated 
from a fever tree called Cinchona succirubra (Demain and Sanchez, 2009). Arteether is an antimalarial 
drug that was derived from artemisinin, which was isolated from a plant called Artemisia annua(Graul, 
2001). Secondary metabolites have contributed significantly to the control of infections, the 
development of the pharmaceutical world, and an increase in the life expectancy of people world-wide 
(Lederberg, 2000). 
 
The screening of natural products is of vital importance, as it assists in the discovery of novel active 
compounds, and the efficacy and safety of their use (Shihabudeen et al., 2010; Ncube et al., 2008). 
The study of phytochemicals also assists in establishing the authenticity of plants, especially when the 
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plants are not easily identifiable, and documentation of such information can be useful even in the 
future. Hence, in this chapter, a phytochemical study of the methanol extracts of B. macowanii, P. 
myrtifolia, Scilla sp. and X. zambesiaca was conducted using Thin Layer Chromatography (TLC) 
fingerprinting, Gas Chromatography Mass Spectrometry (GCMS) and standard phytochemical 
screening methods. 
 
4.2. Methods 
4.2.1. Extract preparation 
The extracts of B. macowanii, P. myrtifolia, Scilla sp and X. zambesiaca were prepared in the same 
manner as described under 2.2.2 in Chapter 2 (see page 29). 
 
4.2.2. Phytochemical analysis of the plant extract 
The extracts were subjected to phytochemical screening tests for tannins, flavonoids, alkaloids, 
saponins, steroids and phenols (Kubmarawa et al., 2007) using standard methods. 
 
4.2.2.1. Detection of tannins and phenols 
The dried powder of the plant extract was boiled in 20 ml of water in a test tube, whereafter it was 
filtered. A few drops of 0.1% ferric chloride were added, and observed for a brownish-green or a blue-
black colouration (Sofowara, 1993; Ayoola et al., 2006). 
 
4.2.2.2. Detection of steroids 
The plant extract was dissolved in 3 ml of CHCl3 and filtered. Concentrated H2SO4 was added to the 
filtrate to form a lower layer. A reddish-brown colour was taken as a positive indication of a steroid ring 
(Igwe et al., 2007). 
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4.2.2.3. Detection of flavonoids  
The flavonoids were tested using The Alkaline Reagent Test, where the extracts were subjected to a 
few drops of sodium hydroxide solution. The formation of an intense yellow colour, which becomes 
colourless when a dilute acid is added to it, indicates the presence of flavonoids (Tiwari et al., 2011). 
 
4.2.2.4. Detection of alkaloids 
Alkaloids were detected using the Dragendroff’s test, where the extracts were individually dissolved in 
water and filtered. The filtrates were treated with Dragendroff’s reagent (a solution of potassium 
Bismuth Iodide). The formation of a red or yellow precipitate indicates the presence of alkaloids 
(Doughari, 2012). 
 
4.2.2.5. Detection of saponins  
The extracts were dissolved in distilled water, and made up to 20mL. The suspension was shaken in a 
graduated cylinder for 15 minutes. A two-centimetre layer of foam indicated the presence of saponins 
(Kokate, 1999; Ayoola et al., 2006). 
 
4.2.2.6. Test for carbohydrates 
One ml of the Fehling’s reagent A and B were mixed; the solution was shaken, and then boiled for  
1 minute.  An equal volume of the test solution was added into the mixture and heated in a boiling water 
bath for 5 – 10 minutes. The formation of a red precipitate indicated the presence of carbohydrates 
(Boxi et al., 2010). 
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4.2.2.7. Test for terpenes (Salkowski test) 
The extracts were mixed in 2 ml of chloroform, and 3 ml of concentrated H2S04 was carefully added to 
the mixture to form a layer. A reddish-brown colouration of the interface indicated positive results for the 
presence of terpenoids (Edeoga et al., 2005).  
 
4.2.2.8. Test for glycosides (Keller-kiliani test) 
The filtrate of the extracts was mixed with 1ml of a mixture glacial acetic acid, ferric chloride and 
concentrated H2SO4. A green-blue colour indicated the presence of glycosides (Parekh and Chanda, 
2007). 
 
4.2.3. TLC fingerprinting 
Chemical components of plant extracts were separated or eluted using aluminium-backed,thin layer 
chromatography plates and solvent systems Ethyl acetate/Methanol/Water (40:5.4:5)(polar/neutral), 
Chloroform/Ethylacetate/Formic acid (5:4:1) (intermediate polarity/acidic), Benzene/Ethanol/Ammonium 
hydroxide (18:2:0.2) (Kotze et al., 2002) (non-polar/basic), and Toluene/Acetone/Ethanol (28.5:57:14.5) 
because they are usually used to isolate compounds that show antimicrobial properties (Loru et al., 
2000). The separated chemical compounds were detected by spraying acidified vanillin (0.1g vanillin: 
28ml methanol: 1ml Sulfuric acid) on the TLC plates where after it was heated at 110 ºC in an incubator 
to allow colour development (Suleiman et al., 2010). The plates were viewed under ultraviolet (UV) light 
at a wavelength of 354 nm. 
 
4.2.4. Gas chromatography mass spectrometry (GCMS) 
The dried extracts were dissolved in ethyl acetate, samples were then centrifuged and analysed by 
GCMS using an Agilent 6890N linked to a Mass Detector 5975B. Total ion chromatograms (TIC) and 
their associated spectra were acquired in full scan mode using the Chemstation software linked to the 
© Central University of Technology, Free State
59 
 
GCMS. Peaks and their associated spectra were then searched using the Wiley 375 Mass Spectral 
Database. Due to the complexity of the chromatograms, there is a certain degree of spectral overlap. 
To overcome this, Automated Mass Spectral Deconvolution and Identification Software (AMDIS) was 
used to separate multiple overlapping spectra lying within single chromatographic peaks. 
 
4.3. Results and discussion 
4.3.1. Phytochemical screening (Standard methods) 
The results of the phytochemical screening of B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca 
using standard methods are indicated in Table 4.1. The presence of secondary metabolites such as 
alkaloids may suggest that the use of B. macowanii might be a good option for the production of 
antimalarial, anticancer, antibacterial (see Chapter 2) and antihypertensive drugs (Wansi et al., 2013). 
The presence of tannins may also indicate that B. macowanii, P. myrtifolia, Scilla sp. and X. 
zambesiaca can be potential sources of antioxidant, antitumor, antiviral and antimicrobial agents 
(Haslam, 1996; Kar, 2007). The presence of flavonoids and phenolics also contribute to anti-
inflammatory and antioxidant activity (Kar, 2007, Walch et al., 2011). Traces of saponins also indicate 
that B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca can be considered for the manufacturing 
of antifungal, anticancer, anti-inflammatory, immune-stimulating and antithrombotic agents (Morrissey 
and Osbourn, 1999; Lacalle-Dubois and Wagner, 2000). The presence of saponins was also identified 
in the aqueous extracts of P. myrtifolia, which were also found to have antifungal properties (Bruneton, 
1995). Terpenes tested positive in all the plant extracts and are known for antimicrobial properties, such 
as antiprotozoal, anthelmintic and antifungal activities (Doughari, 2012; Rubio et al., 2013). The test for 
cardiac glycosides was positive only B. macowanii, suggesting its potential in the treatment of heart 
diseases (Doughari, 2012). The medicinal effects of plants can be attributed to the activity of a single 
compound, or to a synergism of compounds (Eloff et al., 2008). 
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Table: 4.1. Phytochemical content of the plant extracts 
Plant extract  Flavonoids Tannins Saponins Phenols Alkaloids Steroids Carbohydra
tes 
Terpenes Cardiac 
glycosides 
Scilla sp. (entire 
plant) 
+ + + + - + + + - 
Scilla (bulb and 
roots) 
+ + + + - + - + - 
Polygala myrtifolia 
(Leaves and twigs) 
+ + + + - - + + - 
Buxus macowanii 
(Leaves and twigs) 
+ + + + + + + +    + 
Xanthocercis 
zambesiaca (Stem) 
+ + + + - + + + - 
(+) means presence of secondary metabolites 
(-) means absence of secondary metabolites 
 
© Central University of Technology, Free State
61 
 
4.3.2. TLC fingerprinting 
The phytochemical analysis of the plant extracts using TLC fingerprinting after the elution of the 
compounds resulted in different colour changes due to their reaction with the spray reagent used 
(Vanillin/Sulfuric acid) (Figure 4.1). The spray reagent (Vanillin/Sulfuric acid) is usually used to detect 
terpenes and phenylpropanoids. Plants such as B. macowanii and Scilla sp. revealed violet spots after 
being eluted with the solvent system Benzene/Ethanol/Ammonia hydroxide (BEA), Chloroform/Ethyl 
acetate/Formic acid (CEF) and Toluene/Chloroform/Ethanol (TCE). Diterpenes exhibit a violet colour on 
the chromatograms when sprayed with Vanillin/Sulfuric acid. Therefore, it can be suggested that 
diterpenes can also be found in extracts of B. macowanii and Scilla extracts. Research has shown that 
diterpenes can inhibit cancer multiplicity, and therefore plant extracts that indicated the presence of 
diterpenes can be used to manufacture anticancer agents (Martinez et al., 2008). Rf values were not 
indicated because it was a qualitative evaluation of compounds. 
 
Figure 4.1: Vanillin-sprayed TLC chromatograms of the methanol extracts developed in 
Benzene/Ethanol/Ammonia hydroxide: 90:10:1 (BEA), Ethyl acetate/Methanol/Water: 40:5.4:4 (EMW), 
Toluene/Chloroform/Ethanol: 28.5:57:14.5 (TCE), and Chloroform/Ethyl acetate/Formic acid: 5:4:1 
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(CEF). F = B. macowanii, A = Scilla sp. (entire plant), B = Scilla sp. (roots and bulb), E = P. myrtifolia, 
and H = X. zambesiaca. 
 
4.3.3. Gas chromatography mass spectrometry (GCMS) 
GCMS analysis of the plant extracts was conducted using the National Institution of Standard 
Technology (NIST) software and the Wiley Online Library. The identification of the compounds was 
based on the molecular weight, peak area and molecular formula, and only prominent peaks were 
selected for identification. A compound was only regarded as positively identified when the percentage 
of similarities was more than 90%. See annexure A for total ion chromatograms of suggested 
compounds detected from plant extracts of B. macowanii, Scilla sp, P. myrtifolia and X. zambesiaca. 
The GCMS analysis of the leaves and twigs of the extracts of B. macowanii showed that neophytadiene 
was detected at a retention time of 10.92 (as indicated in Table 4.2), and it has been proposed to have 
some antimicrobial activities (Inoue et al., 2005). Neophytadiene has also been reported for the 
treatment of headaches, rheumatism and some skin diseases (Suresh et al., 2010). It has been 
reported that other plants from the genus Buxus, such as B. papillosa, is used to treat rheumatism and 
skin disorders (Cordell, 1981). It can be suggested that the presence of neophytadiene may be the 
reason why B. macowanii and B. papillosa have the ability to treat such ailments. The antimicrobial 
activity (see Chapter 2) of B. macowanii can also be explained by the presence of neophytadiene in its 
extracts. Therefore, it suggests that the plant can be an option for use in the manufacturing of 
antimicrobial drugs and other remedies used to treat headaches, rheumatism and skin conditions.  
 
The GCMS analysis of the plant extracts of Scilla sp. indicated a detection of a number of compounds, 
such as hexadecanoic acid, which was detected at a retention time of 11.8. A study conducted by 
Joshi-Barve et al., (2007) reported that palmitic acid can cause an increase in levels of biologically 
active neutrophil chemoattractant, IL-8, from hepatocytes that can potentially cause hepatic 
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inflammation and liver injury. The findings suggest that the reckless use of Scilla sp. can be potentially 
hazardous. The GCMS analysis of the roots, bulb and plant extracts of Scilla sp. indicated the detection 
of n-hexadecanoic acid at a retention time of 11.8, as indicated in Table 4.2. N-Hexadecanoic acid is a 
compound that is known to have inflammatory activity; therefore, it can also be considered as potential 
compound for use in the manufacturing of anti-inflammatory drugs (Aparna et al., 2012).   
 
The GCMS analysis of the leave and twig extracts of P. myrtifolia indicated the presence of 2-methoxy-
4-vinylphenol at a retention time of 6.87. 2M4VP has been reported to inhibit cancer proliferation and to 
have anti-inflammatory activity (Jeong and Jeong, 2010; Jeong et al., 2011). Anti-inflammatory activity 
has also been reported in other species in the Polygala genus, such as in P. japonica and P. 
cyparissias (El Sayah et al., 1999; Kou et al., 2005; Kou et al., 2006). It is safe to say that P. myrtifolia 
can be considered as the best option for use in the manufacturing of anti-inflammatory and anticancer 
agents, because of the presence of 2M4VP. The GCMS analysis of the stem extracts of X. zambesiaca 
indicated the presence of 2M4VP at a retention time of 6.87. n-Hexadecanoic acid was also detected at 
a retention time of 11.8. The findings also suggest that X. zambesiaca can be considered an option for 
use in the manufacturing of anticancer and anti-inflammatory agents.  
 
Table 4.2: The GCMS analysis of five plant extracts 
Plant extract Suggested 
Compounds 
Retention time  Molecular 
formula 
Molecular weight  
Buxus macowanii 
(Leaves and 
Twigs) 
Neophytadiene 10.92 C20H38 278.5 
Scilla sp. (Whole  
plant) 
Hexadecanoic 
acid  
11.8 C16H32O2 256.4 
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Scilla sp. (roots 
and bulbs) 
n-Hexadecanoic 
acid  
11.8 C16H32O2 256.4 
Polygala 
myrtifolia (Leaves 
and twigs) 
2-methoxy-4-
vinylphenol 
6.87 C9H10O2 150.2 
X. zambesiaca 
(Stem) 
2-methoxy-4-
vinylphenol 
6.87 C9H10O2 150.2 
 n-Hexadecanoic 
acid  
11.8 C16H32O2 256.4 
 
4.4. Conclusions  
The phytochemical screening of B. macowanii, Scilla sp., P. myrtifolia and X. zambesiaca extracts 
indicated that they contain secondary metabolites that are of great importance for the pharmaceutical 
industry. Secondary metabolites, such as alkaloids, flavonoids, polyphenolics, saponins, steroids, and 
terpenes, are present in most of the tested extracts and biological properties have made researchers to 
search for new drug leads in them. Alkaloids, flavonoids, polyphenolics, steroids, terpenes, 
neophytadiene, n-hexadecanoic acid, 2MV4P contain properties that assist with the treatment of 
diseases, such as antimicrobial, anticancer, anti-inflammatory activities, etc. The phytochemical 
screening results suggest that B. macowanii, Scilla sp., P. myrtifolia and X. zambesiaca are plants that 
can be used to manufacture novel drugs for the treatment of infectious diseases. 
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CHAPTER 5 
GENERAL DISCUSSION AND CONCLUSIONS  
5.1. General discussion  
World-wide, medicinal plants are important for the treatment of diseases and are potential sources of 
novel drugs that can overcome the challenges associated with the drugs that are currently available, 
such as drug-resistant pathogens, toxicity and inaccessibility. B. macowanii, Scilla species, P. myrtifolia 
and X. zambesiaca are traditionally used for the treatment of various ailments, such as rheumatism, 
skin disorders, high sugar concentrations, headaches, respiratory problems and gastrointestinal 
problems. The above-mentioned traditional uses classify these plants as major contributors to the 
health care of people who cannot afford or access modern medicine. With all the challenges pertaining 
to the treatment of infectious diseases and the traditional use of the selected plants, it was necessary to 
investigate the antimicrobial activity of the selected plants. The results from the study are summarised 
in Table 5.1 below. 
 
Table 5.1: A summary of the results obtained in the study 
Plant extract Antimicrobial 
activity 
Phytochemical screening Cytotoxicity (CSIR 
Criteria) 
IC50,µg/ml 
B. macowanii 
(Leaves and 
Twigs) 
            + Standard methods: Alkaloids, steroids, 
flavonoids, terpenes, carbohydrates, 
tannins and cardiac glycosides  
Thin Layer Chromatography 
fingerprinting: Diterpenes 
Gas Chromatrophy Mass Spectrometry: 
Neophytadiene 
Moderate hazard 
< 30  
 >5 
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P. myrtifolia 
(Leaves and 
Twigs) 
             - Standard methods: Alkaloids, tannins, 
taponins, phenols, carbohydrates and 
terpenes 
TLC fingerprinting: Negative 
GCMS: 2-methoxy-4-vinylphenol 
Low hazard 
> 100 
Scilla sp. (Whole 
Plant) 
             - Standard methods: Flavonoids, tannins, 
phenols, steroids, carbohydrates and 
terpenes 
TLC fingerprinting: Diterpenes 
GCMS: Hexadecanoic acid 
High hazard 
<5 
Scilla sp. (Roots 
and Bulbs) 
             - Standard methods: Flavonoids, tannins, 
saponins, phenols, steroids and terpenes 
TLC fingerprinting: Diterpenes 
GCMS: n-hexadecanoic acid  
High hazard 
<5 
X. zambesiaca 
(Stem) 
             - Standard method: Flavonoids, tannins, 
saponins, phenols, steroids, 
carbohydrates and terpenes 
TLC fingerprinting: Negative 
GCMS: 2-methoxy-vinylphenol and n-
hexedecanoic acid 
Moderate hazard 
< 30  
 >5 
(+) Activity 
(-) No activivity 
The extracts of Buxus macowanii showed antimicrobial activity against S. aureus, C. perfringens, P. 
aeriginosa, S. epidermidis, C. albicans and C. tropicalis at Minimum Inhibitory Concentration (MIC) of 
2.5 mg/ml, and against E. faecalis and E. coli at an MIC of 1.2mg/ml. B. macowanii was the only plant 
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that showed growth inhibition of all bacterial and fungal species against which it was tested; for this 
reason, it was selected for further studies. This study is the first to report on the antimicrobial activity of 
B. macowanii. P. myrtifolia, Scilla sp and X. zambesiaca did not show any inhibitory effects against the 
tested bacterial and fungal species, although P. myrtifolia was reported to have antibacterial and 
antifungal activities (Lall and Meyer, 1999; Motsei et al., 2003). The inactivity of the plant extracts of X. 
zambesiaca and P. myrtifolia may be due to the choice of the solvent of extraction and the age of the 
extracts.  
 
B. macowanii was further investigated using the TLC bioautography method discussed in Chapter 2, 
for purposes of identifying and locating the antimicrobial compounds against the most affected bacteria 
(E. faecalis). Clear zones on the chromatogram indicated that B. macowanii has antimicrobial 
compounds. Alkaloid and flavonoid spots were located in close proximity to the antimicrobial spots of 
the extracts of B. macowanii. Therefore, it can be suggested that flavonoids and alkaloids contributed 
positively to the antimicrobial activity of the extracts of B. macowanii. The effect of the extracts of B. 
macowanii on the morphology of bacteria (B. cereus) was also studied using the scanning electron 
microscope and the transmission electron microscope (see Chapter 2). The cells of B. cereus indicated 
abnormal morphological properties after treatment with the extracts of B. macowanii, such as a 
distortion of the cell membrane, leakage of the cytoplasmic contents and separation of the cell 
membrane from the cell wall. Most plants that belong to the genus Buxus have been reported to contain 
steroidal alkaloids. Steroidal alkaloids are known to cause cell-membrane disruption, which also leads 
to cytoplasmic content leakage (Wink and Twardowski, 1992; Wink and Latz-Bruning, 1995).The 
morphological properties of bacterial cells that were observed under microscopy after treatment with B. 
macowanii can be attributed to the presence of steroidal alkaloids. B. macowanii can be considered as 
the best option to use for the manufacturing of novel antimicrobial drugs that can overcome the 
challenges associated with the remedies that are currently available. 
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Plants such as B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca are generally used by 
traditional healers to treat various ailments. However, these traditional healers often do not have 
sufficient knowledge of the plants’ toxicity to human cells. Therefore, it is necessary to ensure that the 
plants are safe to be used by humans. The cytotoxicity of the methanol extracts of B. macowanii, P. 
myrtifolia, Scilla sp. and X. zambesiaca was tested against the WI-38 cell line (Normal human fetal lung 
fibroblast) using Sulforhodamine cytotoxicity assay (see Chapter 3), the results of which are 
summarised in Table 5.1. According to CSIR criteria, the extracts of B. macowanii and X. zambesiaca 
exhibited moderate hazardous toxicity against the WI-38 cell line with 20.4 µg/ml and 22.96 µg/ml IC50 
respectively. The bulb, root and entire plant extracts of Scilla sp. showed high-hazard toxicity against 
the WI-38 cell line, with both less than 6.25µg/ml IC50. The leave and twig extracts of P. myrtifolia 
showed low-hazard toxicity or no toxicity against the WI-38 cell line, according to the Council for 
Scientific and Industrial Research (CSIR) criteria. The compounds such as steroids, cardiac glycosides 
and alkaloids (Van Wyk et al., 1997) found in the plant extracts may have contributed to the toxicity that 
the extracts exhibited against the WI-38 cell lines. Although plant extracts such as B. macowanii, Scilla 
sp. and X. zambesiaca exhibited toxicity against the WI-38 cell line, their use in the treatment of 
ailments should not be prohibited; rather, caution must be applied by regulating their administration 
dosage. Structure activity studies and chemical modification experiments that will reduce toxicity and 
maintain the activity of the plant extracts can also be employed, so that the plants can be the best 
option for consideration in the manufacturing of new drugs. 
 
The methanol extracts of B. macowanii, P. myrtifolia, Scilla sp. and X. zambesiaca were subjected to a 
screening of the most important phytochemicals, such as the phenols, flavonoids, alkaloids, terpenes, 
cardiac glycosides, tannins, saponins and steroids (see Chapter 4). The phytochemical screening was 
conducted by using the standard methods, TLC and GCMS, the results of which are summarised in 
© Central University of Technology, Free State
74 
 
Table 5.1. The leaves and twigs of B. macowanii were found to contain all the phytochemicals screened 
for, and may explain why the extracts showed antimicrobial activity against all the microbial species 
against which it was tested. The presence of diterpenes in the extracts of B. macowanii, P. myrtifolia, 
Scilla sp. and X. zambesiaca was tested using TLC (see Chapter 4). The separated compounds were 
detected using acidified vanillin. B. macowanii and bulb, root and entire plant extracts of Scilla sp 
showed the presence of diterpenes on the chromatograms after being eluted by the solvent systems 
Benzene/Ethanol/Ammonia hydroxide (BEA), Chloroform/Ethyl acetate/Formic acid (CEF) and 
Toluene/Chloroform/Ethanol (TCE). GCMS managed to isolate and identify very important compounds 
from the extracts of B. macowanni, P. myrtifolia, Scilla sp. and X. zambesiaca. Neophytadiene was 
detected from the extracts of B. macowanii. The compound was reported to have antimicrobial 
activities, and it can be used to treat headaches, rheumatism and skin disorders (Inoue et al., 2005). N-
hexadecanoic acid was also identified in the extracts of Scilla sp. and X. zambesiaca, which suggests 
that the extracts may be good options for the manufacturing of anti-inflammatory agents. 2M4VP is 
another compound that was identified in the extracts of P. myrtifolia and X. zambesiaca. 2M4VP is 
known for its anticancer and anti-inflammatory activities. According to the CSIR criteria, Scilla sp. 
extracts were reported to have toxicity against human fetal lung fibroblasts (see Chapter 3), and the 
phytochemical screening revealed that the extracts contain Palmitic acid (see Chapter 4). Palmitic acid 
has been reported to be a causative agent of hepatic inflammation and liver injury; therefore, the 
findings could suggest that palmitic acid contributed to the toxicity potential that Scilla sp. extracts 
exhibited against WI-38 (see Chapter 3). The overall phytochemical screening of the plant extracts 
indicated that they contain important compounds that can provide leads to the manufacturing of new 
drugs that can overcome the problems that are associated with the agents that are currently available. 
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5.2. Conclusions and recommendations 
These findings suggest that, to date, plants can still be considered as an important source of medicine 
for the treatment of various diseases. B. macowanii excellently showed that it can be the best option to 
use in the manufacturing of antimicrobial agents. However, isolation and identification of antimicrobial 
compounds using solvents such as diethylamine must be considered for future studies. Although plant 
extracts of P. myrtifolia, Scilla sp. and X. zambesiaca did not show inhibition against the bacterial 
species against which they were tested, phytochemical screening revealed that these plants possess 
other important pharmacological properties, based on the compounds that were identified in them. 
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Annexure A 
 
Total ion chromatogram of hexadecanoic acid that was detected in Scilla sp. 
 
Total ion chromatogram of n-hexadecanoic acid detected from extracts of Scilla sp. and X. zambesiaca 
 
Total ion chromatogram of Phytol, actate or Neophytadiene detected in extracts of Buxus macowanii 
 
Total ion chromatogram of 2-Methoxy-4-vinylphenol detected in extracts of P. myrtifolia and X. 
zambesiaca  
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